INS and diabetes mellitus: The newly identified mtDNA encoded polypeptide MOTS-c improves insulin sensitivity, regulates glycolipid metabolism, and affects mitochondrial metabolism (8, 32), leading to suggestions that MOTS-c could be a new treatment for diabetes, and for reducing myocardial damage in diabetes (33).